Patents Assigned to ProNAI Therapeutics, Inc.
  • Methods and compositions for the inhibition of gene expression
    Patent number: 9393258
    Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
    Type: Grant
    Filed: July 10, 2014
    Date of Patent: July 19, 2016
    Assignee: PRONAI THERAPEUTICS, INC.
    Inventors: Gholamreza Sheikhnehjad, Mina Patel Sooch, Neal Goodwin, David Olson
  • Cancer therapies and pharmaceutical compositions used therein
    Patent number: 8822646
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides co-therapies comprising oligonucleotides plus other therapies to treat cancer.
    Type: Grant
    Filed: March 23, 2012
    Date of Patent: September 2, 2014
    Assignee: ProNAi Therapeutics, Inc.
    Inventors: Neal Clifford Goodwin, James Patrick McGovren
  • Methods and compositions for the inhibition of gene expression
    Patent number: 8815599
    Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
    Type: Grant
    Filed: June 1, 2005
    Date of Patent: August 26, 2014
    Assignee: ProNAi Therapeutics, Inc.
    Inventors: Gholamreza Sheikhnehjad, Mina Patel Sooch, Neal Clifford Goodwin, David Olson
  • Amphoteric Liposome Formulation
    Publication number: 20130323298
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
    Type: Application
    Filed: January 28, 2013
    Publication date: December 5, 2013
    Applicants: Novosom AG, ProNAi Therapeutics, Inc.
    Inventors: Neal Clifford Goodwin, Gerold Endert, Natalie Herzog, Yvonne Kerwitz, Steffen Panzner, Wendi Rodrigueza
  • Amphoteric liposome formulation
    Patent number: 8367628
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides DNAi oligonucleotides sequestered by amphoteric liposomes for the treatment of cancer.
    Type: Grant
    Filed: December 1, 2006
    Date of Patent: February 5, 2013
    Assignees: ProNAi Therapeutics, Inc., Novosom AG
    Inventors: Neal Clifford Goodwin, Gerold Endert, Natalie Herzog, Yvonne Kerwitz, Steffen Panzner, Wendi Rodrigueza
  • Cancer Therapies and Pharmaceutical Compositions Used Therein
    Publication number: 20120294851
    Abstract: The invention relates to compositions and methods to inhibit gene expression. In particular, the invention provides co-therapies comprising oligonucleotides plus other therapies to treat cancer.
    Type: Application
    Filed: March 23, 2012
    Publication date: November 22, 2012
    Applicant: ProNAi Therapeutics,Inc.
    Inventors: Neal Clifford Goodwin, J. Patrick McGovren
  • Methods and Compositions for the Inhibition of Gene Expression
    Publication number: 20110135710
    Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
    Type: Application
    Filed: June 1, 2005
    Publication date: June 9, 2011
    Applicant: PRONAI THERAPEUTICS, INC.
    Inventors: Gholamreza Sheikhnehjad, Mina Patel Sooch, Neal Goodwin, David Olson
  • Methods and compositions for cancer therapy
    Patent number: 7807647
    Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
    Type: Grant
    Filed: September 22, 2005
    Date of Patent: October 5, 2010
    Assignee: ProNAI Therapeutics, Inc.
    Inventors: Gholamreza Sheikhnejad, Neal Goodwin, David Olson
  • Methods and compositions for the inhibition of gene expression
    Patent number: 7498315
    Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: March 3, 2009
    Assignee: ProNAI Therapeutics, Inc.
    Inventors: Gholamreza Sheikhnehjad, Mina Patel Sooch, Neal Goodwin, David Olson
  • Methods and compositions for the inhibition of gene expression
    Publication number: 20060198828
    Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
    Type: Application
    Filed: June 1, 2004
    Publication date: September 7, 2006
    Applicant: ProNAi Therapeutics, Inc.
    Inventors: Gholamreza Sheikhnejad, Mina Sooch, Neal Goodwin, David Olson
  • Methods and compositions for the inhibition of gene expression
    Publication number: 20060073596
    Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
    Type: Application
    Filed: June 1, 2004
    Publication date: April 6, 2006
    Applicant: ProNAi Therapeutics, Inc.
    Inventors: Gholamreza Sheikhnehjad, Mina Sooch, Neal Goodwin, David Olson
  • Methods and compositions for the inhibition of gene expression
    Publication number: 20050287667
    Abstract: The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers.
    Type: Application
    Filed: June 1, 2004
    Publication date: December 29, 2005
    Applicant: ProNAi Therapeutics, Inc.
    Inventors: Reza Sheikhnejad, Mina Sooch, Neal Goodwin, David Olson